{
 "metadata": {
  "name": "",
  "signature": "sha256:f62ee7ff8916bbea42b641ac3e56d23d0af270196289e4170394a1c8d5dea654"
 },
 "nbformat": 3,
 "nbformat_minor": 0,
 "worksheets": [
  {
   "cells": [
    {
     "cell_type": "heading",
     "level": 2,
     "metadata": {},
     "source": [
      "Deep semantic choices for job 716173 with the 4 relation types"
     ]
    },
    {
     "cell_type": "markdown",
     "metadata": {},
     "source": [
      "2015-04-22 Tong Shu Li"
     ]
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "import pandas as pd\n",
      "import matplotlib.pyplot as plt\n",
      "\n",
      "%matplotlib inline\n",
      "%pylab inline"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "Populating the interactive namespace from numpy and matplotlib\n"
       ]
      }
     ],
     "prompt_number": 1
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "from itertools import islice\n",
      "from collections import Counter"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 2
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "import sys\n",
      "sys.path.append(\"/home/toby/crowdsourcing/drug_disease_semantics/src/\")\n",
      "\n",
      "from filter_data import filter_data\n",
      "from true_relation_type import get_euadr_relation_type\n",
      "from aggregate_results import aggregate_results\n",
      "from aggregate_votes import aggregate_votes\n",
      "from get_orig_problem import get_orig_problem"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 3
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "sys.path.append(\"/home/toby/global_util/\")\n",
      "from file_util import read_file"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 4
    },
    {
     "cell_type": "markdown",
     "metadata": {},
     "source": [
      "Read our data:"
     ]
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "settings = {\n",
      "    \"loc\": \"/home/toby/crowdsourcing/drug_disease_semantics/data/\",\n",
      "    \"fname\": \"job_716713_full_with_untrusted_and_unfinished.tsv\",\n",
      "    \"data_subset\": \"normal\",\n",
      "    \"min_accuracy\": 0.7,\n",
      "    \"max_accuracy\": 1.0,\n",
      "    \"id_column\": \"pub_rel_id\"\n",
      "}"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 5
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "raw_data = filter_data(settings)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 6
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "euadr_answer = get_euadr_relation_type(settings)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 7
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "len(raw_data)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 8,
       "text": [
        "1022"
       ]
      }
     ],
     "prompt_number": 8
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "def create_match(gold_std_answer):\n",
      "    def match(identifier, crowd_choice):\n",
      "        return int(crowd_choice == gold_std_answer[identifier])\n",
      "    \n",
      "    return match"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 9
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "match_obj = create_match(euadr_answer)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 10
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "results = aggregate_results(\"pub_rel_id\", \"broad_rel_type\", raw_data, match_obj)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 11
    },
    {
     "cell_type": "markdown",
     "metadata": {},
     "source": [
      "Look at the results:"
     ]
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "def determine_matches(results):\n",
      "    matches = []\n",
      "    mismatches = []\n",
      "    for rel_id, group in results.groupby(\"pub_rel_id\"):\n",
      "        if group.iloc[0][\"match\"] == 1:\n",
      "            matches.append(rel_id)\n",
      "        else:\n",
      "            mismatches.append(rel_id)\n",
      "            \n",
      "    return (matches, mismatches)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 12
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "matches, mismatches = determine_matches(results)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 13
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "len(matches)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 14,
       "text": [
        "165"
       ]
      }
     ],
     "prompt_number": 14
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "len(mismatches)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 15,
       "text": [
        "79"
       ]
      }
     ],
     "prompt_number": 15
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "def deep_sem_summary(work_units):\n",
      "    temp = []\n",
      "    for rel_id in work_units:\n",
      "        subset = results.query(\"pub_rel_id == '{0}'\".format(rel_id))\n",
      "        top_choice = subset.iloc[0][\"broad_rel_type\"]\n",
      "        \n",
      "        if top_choice in [\"positive\", \"speculative\"]:\n",
      "            raw_subset = raw_data.query(\"pub_rel_id == '{0}'\".format(rel_id))\n",
      "\n",
      "            top_subset = raw_subset.query(\"broad_rel_type == '{0}'\".format(top_choice))\n",
      "\n",
      "            ans = aggregate_votes(\"deep_semantics\", top_subset)\n",
      "            \n",
      "            total_vote_score = sum(ans[\"conf_score\"])\n",
      "            percent_agree = ans[\"conf_score\"] / total_vote_score\n",
      "            \n",
      "            ans[\"percent_agree\"] = percent_agree\n",
      "            ans.insert(0, \"pub_rel_id\", rel_id)\n",
      "            \n",
      "            ans = ans.sort([\"conf_score\"], ascending = False)\n",
      "            \n",
      "            temp.append(ans)\n",
      "            \n",
      "    return pd.concat(temp)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 16
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "deep_sem_res = deep_sem_summary(matches)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 17
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "loc = \"/home/toby/crowdsourcing/drug_disease_semantics/data/\"\n",
      "\n",
      "pub_to_raw_mapping = dict()\n",
      "for line in islice(read_file(loc + \"raw_to_toby_mapping.txt\"), 1, None):\n",
      "    pub_rel_id, raw_rel_id, num_agree = line.split('|')\n",
      "    pub_to_raw_mapping[pub_rel_id] = (raw_rel_id, int(num_agree))"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 18
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "orig_problem = get_orig_problem(\"pub_rel_id\", raw_data)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 19
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "def summary(work_units):\n",
      "    for identifier in work_units:\n",
      "        subset = results.query(\"pub_rel_id == '{0}'\".format(identifier))\n",
      "        \n",
      "        unit_id = raw_data.query(\"pub_rel_id == '{0}'\".format(identifier)).iloc[0][\"_unit_id\"]\n",
      "        \n",
      "        deep_subset = deep_sem_res.query(\"pub_rel_id == '{0}'\".format(identifier))\n",
      "        \n",
      "        print \"Unit id: {0}\".format(unit_id)\n",
      "        print\n",
      "        print \"EU-ADR answer:\", euadr_answer[identifier]\n",
      "        print \"Experts agree: {0}/3\".format(pub_to_raw_mapping[identifier][1])\n",
      "        print\n",
      "        print subset\n",
      "        print\n",
      "        if not deep_subset.empty:\n",
      "            print deep_subset\n",
      "            print\n",
      "        print orig_problem[identifier][3]\n",
      "        print\n",
      "        print \"============================================================\""
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 20
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "summary(matches)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "Unit id: 706124714\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "       pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_0       positive      2.5589          3              1      1\n",
        "\n",
        "       pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_0      may_cause      2.5589          3              1\n",
        "\n",
        "Body height, weight and obesity increase the risk of [[venous thrombosis]], especially obesity in women using [[oral contraceptives]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124715\n",
        "\n",
        "EU-ADR answer: false\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_10          false      4.2055          5       0.845378      1\n",
        "1  drug_disease_10       negative      0.7692          1       0.154622      0\n",
        "\n",
        "ET-1 mRNA expression was significantly higher in patients with [[CsA]]-induced gingival overgrowth (P <0.001) than in patients with [[periodontitis]] and the controls.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124805\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "2  drug_disease_100       positive      4.3753          5       0.574858   \n",
        "0  drug_disease_100          false      1.7333          2       0.227733   \n",
        "1  drug_disease_100       negative      1.5025          2       0.197409   \n",
        "\n",
        "   match  \n",
        "2      1  \n",
        "0      0  \n",
        "1      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_100  used_to_treat      4.3753          5              1\n",
        "\n",
        "Similarly, the same regimen of posaconazole reduced [[invasive fungal infections]] (95% CI -9.7 to -2.5) and aspergillosis (CI not reported, p < 0.001) when compared with fluconazole and [[itraconazole]] in neutropenic patients.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124787\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_101       positive      2.3788          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_101      may_cause      2.3788          3              1\n",
        "\n",
        "The most common adverse effects associated with the use of [[posaconazole]] include headache, fever, [[nausea]], vomiting, and diarrhea.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124869\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_102       positive      2.5879          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_102      may_cause      2.5879          3              1\n",
        "\n",
        "The most common adverse effects associated with the use of [[posaconazole]] include headache, fever, nausea, [[vomiting]], and diarrhea.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124848"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "2  drug_disease_103       positive      4.3053          5       0.731597   \n",
        "0  drug_disease_103          false      0.8462          1       0.143794   \n",
        "1  drug_disease_103       negative      0.7333          1       0.124609   \n",
        "\n",
        "   match  \n",
        "2      1  \n",
        "0      0  \n",
        "1      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_103  used_to_treat      4.3053          5              1\n",
        "\n",
        "Similarly, the same regimen of [[posaconazole]] reduced invasive fungal infections (95% CI -9.7 to -2.5) and [[aspergillosis]] (CI not reported, p < 0.001) when compared with fluconazole and itraconazole in neutropenic patients.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124890\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_104       positive      2.6092          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_104  used_to_treat      2.6092          3              1\n",
        "\n",
        "Similarly, the same regimen of [[posaconazole]] reduced [[invasive fungal infections]] (95% CI -9.7 to -2.5) and aspergillosis (CI not reported, p < 0.001) when compared with fluconazole and itraconazole in neutropenic patients.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706985414\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "1  drug_disease_105       positive      2.4421          3       0.745588   \n",
        "0  drug_disease_105       negative      0.8333          1       0.254412   \n",
        "\n",
        "   match  \n",
        "1      1  \n",
        "0      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_105      may_cause      2.4421          3              1\n",
        "\n",
        "The most common adverse effects associated with the use of [[posaconazole]] include [[headache]], fever, nausea, vomiting, and diarrhea.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124686\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "2  drug_disease_108       positive      5.3364          6       0.682867   \n",
        "0  drug_disease_108          false      1.7091          2       0.218703   \n",
        "1  drug_disease_108       negative      0.7692          1       0.098430   \n",
        "\n",
        "   match  \n",
        "2      1  \n",
        "0      0  \n",
        "1      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_108  used_to_treat      4.4133          5       0.827018\n",
        "0  drug_disease_108      may_cause      0.9231          1       0.172982\n",
        "\n",
        "Similarly, the same regimen of posaconazole reduced [[invasive fungal infections]] (95% CI -9.7 to -2.5) and aspergillosis (CI not reported, p < 0.001) when compared with [[fluconazole]] and itraconazole in neutropenic patients.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124756\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "1  drug_disease_11       positive      1.9091          2       0.696142      1\n",
        "0  drug_disease_11       negative      0.8333          1       0.303858      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_11      may_cause      1.9091          2              1"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "ET-1 mRNA expression was significantly higher in patients with [[CsA]]-induced [[gingival overgrowth]] (P <0.001) than in patients with periodontitis and the controls.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124830\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_110       positive      2.3788          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_110  used_to_treat      1.6515          2       0.694258\n",
        "0  drug_disease_110          other      0.7273          1       0.305742\n",
        "\n",
        "[[Posaconazole]], in doses of 200 mg 3 times daily, reduced breakthrough invasive fungal infections (OR 0.30; 95% CI 0.12 to 0.71) and [[aspergillosis]] incidence (OR 0.31; 95% CI 0.13 to 0.75) in patients receiving hematopoietic stem-cell transplants compared with those receiving fluconazole.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124775\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "1  drug_disease_111       positive      2.5901          3       0.764019   \n",
        "0  drug_disease_111          false      0.8000          1       0.235981   \n",
        "\n",
        "   match  \n",
        "1      1  \n",
        "0      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_111  used_to_treat      2.5901          3              1\n",
        "\n",
        "[[Posaconazole]], in doses of 200 mg 3 times daily, reduced breakthrough [[invasive fungal infections]] (OR 0.30; 95% CI 0.12 to 0.71) and aspergillosis incidence (OR 0.31; 95% CI 0.13 to 0.75) in patients receiving hematopoietic stem-cell transplants compared with those receiving fluconazole.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124885\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_112       positive      2.5879          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_112  used_to_treat      2.5879          3              1\n",
        "\n",
        "Posaconazole is noninferior to [[fluconazole]] for treatment of [[oropharyngeal candidiasis]] (95% CI -6.6 to 5.0), but necessity for this indication remains unclear, as many other treatment options exist.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124821\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_113       positive      2.4848          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_113  used_to_treat      1.6515          2       0.664641\n",
        "0  drug_disease_113      may_cause      0.8333          1       0.335359\n",
        "\n",
        "Posaconazole, in doses of 200 mg 3 times daily, reduced breakthrough [[invasive fungal infections]] (OR 0.30; 95% CI 0.12 to 0.71) and aspergillosis incidence (OR 0.31; 95% CI 0.13 to 0.75) in patients receiving hematopoietic stem-cell transplants compared with those receiving [[fluconazole]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124679"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "1  drug_disease_114       positive      4.6257          5       0.569576   \n",
        "0  drug_disease_114          false      3.4956          4       0.430424   \n",
        "\n",
        "   match  \n",
        "1      1  \n",
        "0      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_114  used_to_treat      3.7026          4       0.800441\n",
        "0  drug_disease_114      may_cause      0.9231          1       0.199559\n",
        "\n",
        "Posaconazole, in doses of 200 mg 3 times daily, reduced breakthrough invasive fungal infections (OR 0.30; 95% CI 0.12 to 0.71) and [[aspergillosis]] incidence (OR 0.31; 95% CI 0.13 to 0.75) in patients receiving hematopoietic stem-cell transplants compared with those receiving [[fluconazole]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124917\n",
        "\n",
        "EU-ADR answer: speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "1  drug_disease_115    speculative      4.8437          6       0.655733   \n",
        "0  drug_disease_115       positive      2.5430          3       0.344267   \n",
        "\n",
        "   match  \n",
        "1      1  \n",
        "0      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_115  used_to_treat      2.5165          3       0.519541\n",
        "0  drug_disease_115      may_cause      2.3272          3       0.480459\n",
        "\n",
        "While some beneficial neuromotor effects of succimer therapy were observed in the present study there remains several unanswered questions such as how long these effects will persist and how [[succimer]] therapy modifies lead-associated [[cerebellar deficits]] manifesting as perturbations in vestibular and/or proprioception systems for postural balance and functional locomotion.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706989513\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_117       positive      2.4451          3       0.740446   \n",
        "1  drug_disease_117    speculative      0.8571          1       0.259554   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "1      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_117      may_cause      2.4451          3              1\n",
        "\n",
        "It is well known that [[tobacco smoke]] exposure is related to the risk of developing [[cardiovascular diseases]] and events.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124836\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_118       positive      2.4745          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_118  used_to_treat      2.4745          3              1\n",
        "\n",
        "[[Tibolone]] is a selective tissue estrogenic activity regulator, approved for the treatment of [[vasomotor symptoms]] in postmenopausal women.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124687\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_12       positive      4.2616          5       0.840668      1\n",
        "1  drug_disease_12    speculative      0.8077          1       0.159332      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_12      may_cause      4.2616          5              1"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "These results suggest that CsA can modulate the expression of ET-1 in gingival fibroblasts and [[CsA]]-induced [[gingival overgrowth]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124702\n",
        "\n",
        "EU-ADR answer: negative\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_126       negative       2.397          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "We found no evidence of impaired control of the carbohydrate and lipid metabolism or aggravation of [[vascular lesions]] during the two years an [[etonogestrel]] implant was used by diabetic women.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124694\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_127       positive      5.1121          6       0.745802   \n",
        "1  drug_disease_127    speculative      1.7424          2       0.254198   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "1      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_127  used_to_treat      5.1121          6              1\n",
        "\n",
        "[[Oritavancin]]: a new promising agent in the treatment of [[infections due to Gram-positive pathogens]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124772\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_128       positive      2.4854          3        0.75473   \n",
        "1  drug_disease_128    speculative      0.8077          1        0.24527   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "1      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_128      may_cause      2.4854          3              1\n",
        "\n",
        "Our findings support that ecstasy use, or [[ecstasy/cannabis]] synergic effects, are responsible for the sub-clinical deficits observed in ecstasy polydrug users, and provides additional evidence for [[long-term cognitive impairment]] owing to ecstasy consumption in the context of polydrug use.\n",
        "\n",
        "============================================================\n",
        "Unit id: 707282367\n",
        "\n",
        "EU-ADR answer: false\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_13          false      2.3596          3              1      1\n",
        "\n",
        "Gingival samples were collected from eight normal healthy individuals, eight patients with [[periodontitis]], and eight patients with cyclosporin A ([[CsA]])-induced gingival overgrowth.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124785\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_136       positive      2.5078          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_136      may_cause      2.5078          3              1\n",
        "\n",
        "Adverse events were similar across treatment groups except for higher rates of [[anemia]] in the groups receiving [[ribavirin]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124764"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_137       positive      2.5078          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_137  used_to_treat      2.5078          3              1\n",
        "\n",
        "Sustained virologic response (SVR) rates of 50%-60% have been achieved in patients with [[chronic hepatitis C genotype 4]] treated with peginterferon plus [[ribavirin]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124877\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_139       positive      1.7500          2       0.704707   \n",
        "1  drug_disease_139    speculative      0.7333          1       0.295293   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "1      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_139      may_cause        1.75          2              1\n",
        "\n",
        "For exposure levels within standard recommended guidelines, [[radioisotopes]] are far more likely to play a role in the occurrence of [[spontaneous abortions]] than X-rays.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124688\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_14       positive      2.4221          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_14      may_cause      2.4221          3              1\n",
        "\n",
        "Gingival samples were collected from eight normal healthy individuals, eight patients with periodontitis, and eight patients with [[cyclosporin A]] (CsA)-induced [[gingival overgrowth]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124719\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_141       positive      2.6754          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_141  used_to_treat      1.8421          2       0.688533\n",
        "0  drug_disease_141      may_cause      0.8333          1       0.311467\n",
        "\n",
        "An open multicenter phase II trial of weekly [[docetaxel]] for [[advanced-stage non-small-cell lung cancer]] in elderly patients with significant comorbidity and/or poor performance status: The GFPC 02-02b study.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124882\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_142       positive      2.4148          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_142      may_cause      2.4148          3              1\n",
        "\n",
        "Contrarily, [[LABA]] showed a significant increase in [[asthma-related deaths]] (Relative Risk=3.83; 95% CI, 1.21-12.14).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124765"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_144       positive      2.4245          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_144  used_to_treat      2.4245          3              1\n",
        "\n",
        "Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with [[PTCL]] received three courses of [[high-dose cyclophosphamide]] 2000 mg/m(2)/day, adriamycin 90 mg/m(2)/day, vincristine and prednisone alternating with three courses of etoposide, cisplatin, cytarabine and prednisone.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124812\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_145       positive      2.5873          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_145  used_to_treat      1.7748          2       0.685966\n",
        "0  drug_disease_145      may_cause      0.8125          1       0.314034\n",
        "\n",
        "Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with [[PTCL]] received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, [[adriamycin]] 90 mg/m(2)/day, vincristine and prednisone alternating with three courses of etoposide, cisplatin, cytarabine and prednisone.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124829\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_146       positive      2.5598          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_146  used_to_treat      2.5598          3              1\n",
        "\n",
        "Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with [[PTCL]] received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, adriamycin 90 mg/m(2)/day, vincristine and prednisone alternating with three courses of etoposide, [[cisplatin]], cytarabine and prednisone.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124820\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_147       positive      2.5873          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_147  used_to_treat      1.7748          2       0.685966\n",
        "0  drug_disease_147      may_cause      0.8125          1       0.314034\n",
        "\n",
        "Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with [[PTCL]] received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, adriamycin 90 mg/m(2)/day, vincristine and prednisone alternating with three courses of etoposide, cisplatin, cytarabine and [[prednisone]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124744\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "2  drug_disease_148       positive      3.4811          4       0.449900   \n",
        "0  drug_disease_148          false      1.7564          2       0.226998   \n",
        "3  drug_disease_148    speculative      1.7308          2       0.223690   \n",
        "1  drug_disease_148       negative      0.7692          1       0.099412   \n",
        "\n",
        "   match  \n",
        "2      1  \n",
        "0      0  \n",
        "3      0  \n",
        "1      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_148  used_to_treat      3.4811          4              1"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with [[PTCL]] received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, adriamycin 90 mg/m(2)/day, [[vincristine]] and prednisone alternating with three courses of etoposide, cisplatin, cytarabine and prednisone.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124770\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "1  drug_disease_149       positive      4.1183          5       0.834255   \n",
        "0  drug_disease_149          false      0.8182          1       0.165745   \n",
        "\n",
        "   match  \n",
        "1      1  \n",
        "0      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_149  used_to_treat      4.1183          5              1\n",
        "\n",
        "Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with [[PTCL]] received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, adriamycin 90 mg/m(2)/day, vincristine and prednisone alternating with three courses of etoposide, cisplatin, [[cytarabine]] and prednisone.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124768\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_15       positive      4.0652          5       0.719695      1\n",
        "1  drug_disease_15    speculative      1.5833          2       0.280305      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_15  used_to_treat      4.0652          5              1\n",
        "\n",
        "The evidence suggests that [[montelukast]] is an effective monotherapy controller in children with [[mild asthma]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 707287260\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_150       positive        2.85          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_150  used_to_treat        2.85          3              1\n",
        "\n",
        "Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with [[PTCL]] received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, adriamycin 90 mg/m(2)/day, vincristine and prednisone alternating with three courses of [[etoposide]], cisplatin, cytarabine and prednisone.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124740\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_151       positive       2.397          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_151  used_to_treat      1.6278          2       0.679099\n",
        "0  drug_disease_151      may_cause      0.7692          1       0.320901\n",
        "\n",
        "Plasma [[ziprasidone]] levels ranged from 20 ng/mL to 160 ng/mL (mean: 75.8 ng/mL) and were significantly related to the improvement in [[negative symptoms]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124683\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_153       positive      2.6322          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  "
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_153      may_cause      2.6322          3              1\n",
        "\n",
        "Characteristic features of an [[inflammation]] induced by [[bevacizumab]] injection include an early onset with painless loss in VA mostly without conjunctival or ciliary injection.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124794\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_154       positive      2.4745          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_154  used_to_treat      1.6745          2       0.676702\n",
        "0  drug_disease_154      may_cause      0.8000          1       0.323298\n",
        "\n",
        "Administration of full-dose R-CHOP (rituximab/cyclophosphamide/doxorubicin/vincristine/[[prednisone]]) chemotherapy is important to maximize response in patients with intermediate-or [[high-grade non-Hodgkin lymphoma]] but might be difficult in older patients.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124919\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_155       positive      2.5879          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_155  used_to_treat      2.5879          3              1\n",
        "\n",
        "Administration of full-dose R-CHOP ([[rituximab]]/cyclophosphamide/doxorubicin/vincristine/prednisone) chemotherapy is important to maximize response in patients with intermediate-or [[high-grade non-Hodgkin lymphoma]] but might be difficult in older patients.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124759\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_156       positive      2.6209          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_156  used_to_treat      2.6209          3              1\n",
        "\n",
        "Administration of full-dose R-CHOP (rituximab/cyclophosphamide/[[doxorubicin]]/vincristine/prednisone) chemotherapy is important to maximize response in patients with intermediate-or [[high-grade non-Hodgkin lymphoma]] but might be difficult in older patients.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124776\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_157       positive      2.3778          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_157  used_to_treat      2.3778          3              1\n",
        "\n",
        "Administration of full-dose R-CHOP (rituximab/[[cyclophosphamide]]/doxorubicin/vincristine/prednisone) chemotherapy is important to maximize response in patients with intermediate-or [[high-grade non-Hodgkin lymphoma]] but might be difficult in older patients.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124786"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_158       positive      2.6744          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_158  used_to_treat      2.6744          3              1\n",
        "\n",
        "Administration of full-dose R-CHOP (rituximab/cyclophosphamide/doxorubicin/[[vincristine]]/prednisone) chemotherapy is important to maximize response in patients with intermediate-or [[high-grade non-Hodgkin lymphoma]] but might be difficult in older patients.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124858\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_159       positive      2.6092          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_159      may_cause      1.8015          2       0.690442\n",
        "1  drug_disease_159  used_to_treat      0.8077          1       0.309558\n",
        "\n",
        "Compared with the general population, [[methotrexate]]-treated RA patients have an increased incidence of melanoma, non-Hodgkin's lymphoma, and [[lung cancer]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124881\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_160       positive      2.3596          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_160      may_cause      2.3596          3              1\n",
        "\n",
        "Compared with the general population, [[methotrexate]]-treated RA patients have an increased incidence of [[melanoma]], non-Hodgkin's lymphoma, and lung cancer.\n",
        "\n",
        "============================================================\n",
        "Unit id: 707218352\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_161       positive      2.5421          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_161      may_cause      2.5421          3              1\n",
        "\n",
        "Compared with the general population, [[methotrexate]]-treated RA patients have an increased incidence of melanoma, [[non-Hodgkin's lymphoma]], and lung cancer.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124795\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_163       positive      2.5873          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_163      may_cause      2.5873          3              1\n",
        "\n",
        "There was an estimated 50% excess risk of malignancy among [[methotrexate]]-exposed RA patients relative to the general population (SIR 1.5, 95% confidence interval [95% CI] 1.2-1.9), with a 3-fold increase in melanoma (SIR 3.0, 95% CI 1.2-6.2), a 5-fold increase in [[non-Hodgkin's lymphoma]] (SIR 5.1, 95% CI 2.2-10.0), and an almost 3-fold increase in lung cancer (SIR 2.9, 95% CI 1.6-4.8).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124757"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "1  drug_disease_164       positive      2.5971          3       0.757084   \n",
        "0  drug_disease_164          false      0.8333          1       0.242916   \n",
        "\n",
        "   match  \n",
        "1      1  \n",
        "0      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_164      may_cause      2.5971          3              1\n",
        "\n",
        "There was an estimated 50% excess risk of malignancy among [[methotrexate]]-exposed RA patients relative to the general population (SIR 1.5, 95% confidence interval [95% CI] 1.2-1.9), with a 3-fold increase in melanoma (SIR 3.0, 95% CI 1.2-6.2), a 5-fold increase in non-Hodgkin's lymphoma (SIR 5.1, 95% CI 2.2-10.0), and an almost 3-fold increase in [[lung cancer]] (SIR 2.9, 95% CI 1.6-4.8).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124835\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_165       positive      2.5078          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_165      may_cause      2.5078          3              1\n",
        "\n",
        "There was an estimated 50% excess risk of malignancy among [[methotrexate]]-exposed RA patients relative to the general population (SIR 1.5, 95% confidence interval [95% CI] 1.2-1.9), with a 3-fold increase in [[melanoma]] (SIR 3.0, 95% CI 1.2-6.2), a 5-fold increase in non-Hodgkin's lymphoma (SIR 5.1, 95% CI 2.2-10.0), and an almost 3-fold increase in lung cancer (SIR 2.9, 95% CI 1.6-4.8).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124852\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_166       positive      2.5598          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_166  used_to_treat      2.5598          3              1\n",
        "\n",
        "Incidence of melanoma and other malignancies among [[rheumatoid arthritis]] patients treated with [[methotrexate]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124894\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_167       positive      2.6836          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_167  used_to_treat      1.8503          2       0.689484\n",
        "0  drug_disease_167      may_cause      0.8333          1       0.310516\n",
        "\n",
        "To determine cancer risk in a cohort of 459 [[rheumatoid arthritis]] (RA) patients treated with [[methotrexate]] in community practice.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124912\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_168       positive      1.6648          2       0.689415   \n",
        "1  drug_disease_168    speculative      0.7500          1       0.310585   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "1      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_168  used_to_treat      0.8571          1       0.514837\n",
        "0  drug_disease_168      may_cause      0.8077          1       0.485163\n",
        "\n",
        "To determine [[cancer]] risk in a cohort of 459 rheumatoid arthritis (RA) patients treated with [[methotrexate]] in community practice.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124828"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_169       positive      2.5666          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_169      may_cause      1.7666          2       0.688304\n",
        "1  drug_disease_169  used_to_treat      0.8000          1       0.311696\n",
        "\n",
        "Incidence of melanoma and other [[malignancies]] among rheumatoid arthritis patients treated with [[methotrexate]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124721\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_170       positive      2.4892          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_170      may_cause      1.6559          2       0.665234\n",
        "1  drug_disease_170  used_to_treat      0.8333          1       0.334766\n",
        "\n",
        "Incidence of [[melanoma]] and other malignancies among rheumatoid arthritis patients treated with [[methotrexate]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124803\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_172       positive      2.5666          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_172      may_cause      2.5666          3              1\n",
        "\n",
        "Absence of villin predisposes mice to [[dextran sodium sulfate]]-induced [[colitis]] by promoting apoptosis.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124816\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "1  drug_disease_175       positive      3.3668          4       0.808006   \n",
        "0  drug_disease_175          false      0.8000          1       0.191994   \n",
        "\n",
        "   match  \n",
        "1      1  \n",
        "0      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_175      may_cause      3.3668          4              1\n",
        "\n",
        "Dental surgery for these children has historically consisted of decreasing and/or discontinuing the oral anticoagulant and instituting [[heparin]] therapy prior to the planned dental procedure, which can result in [[thromboembolism]] and increased morbidity and mortality.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124727\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_176       positive      2.4221          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_176  used_to_treat      2.4221          3              1\n",
        "\n",
        "Finally, in non-small cell lung cancer (NSCLC) in patients' progressing on chemotherapy [[sutent]] was able to achieve a 10% response rate, a level of activity similar to those documented by other agents approved for [[lung cancer]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124793"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_177       positive      2.5078          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_177  used_to_treat      2.5078          3              1\n",
        "\n",
        "In several phase I/II/III studies, [[sutent]] was found to be effective as second and first line treatment in [[metastatic renal cell carcinoma]] (RCC).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124911\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_178       positive      2.5879          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_178  used_to_treat      2.5879          3              1\n",
        "\n",
        "Finally, in non-small cell lung cancer ([[NSCLC]]) in patients' progressing on chemotherapy [[sutent]] was able to achieve a 10% response rate, a level of activity similar to those documented by other agents approved for lung cancer.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124763\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_179       positive       2.397          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_179  used_to_treat       2.397          3              1\n",
        "\n",
        "[[Sutent]] was also effective as second line treatment in patients with gastrointestinal stromal tumors ([[GIST]]) with 8% response rate, 70% stable disease and a 20-month median survival.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124737\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_180       positive       2.397          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_180  used_to_treat       2.397          3              1\n",
        "\n",
        "In addition, a phase II study in multitreated women with [[breast cancer]], [[sutent]] demonstrated a moderate activity with 16% clinical benefit.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124739\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_181       positive      2.6039          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_181  used_to_treat      2.6039          3              1\n",
        "\n",
        "[[Epoetin beta]] effectively increases hemoglobin levels, reduces the need for transfusions and improves the quality of life in patients with symptomatic chemotherapy-induced [[anemia]] with a range of solid tumors and lymphoid malignancies.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124761"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_184       positive       2.397          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_184  used_to_treat       2.397          3              1\n",
        "\n",
        "During the induction phase, tacrolimus or cyclosporine, [[mycophenolate mofetil]], and methylprednisolone were used for [[immunosuppression]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124907\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_185       positive       2.609          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_185  used_to_treat       2.609          3              1\n",
        "\n",
        "During the induction phase, [[tacrolimus]] or cyclosporine, mycophenolate mofetil, and methylprednisolone were used for [[immunosuppression]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124902\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_186       positive      2.5879          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_186  used_to_treat      2.5879          3              1\n",
        "\n",
        "During the induction phase, tacrolimus or cyclosporine, mycophenolate mofetil, and [[methylprednisolone]] were used for [[immunosuppression]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124758\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_187       positive      2.7424          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_187  used_to_treat      2.7424          3              1\n",
        "\n",
        "During the induction phase, tacrolimus or [[cyclosporine]], mycophenolate mofetil, and methylprednisolone were used for [[immunosuppression]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124797\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_188       positive      2.5598          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_188      may_cause      2.5598          3              1\n",
        "\n",
        "The most frequent and the most troublesome adverse effect of [[interferon]] plus ribavirin-based therapy is [[anaemia]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124709"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_189       positive      2.4892          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_189      may_cause      2.4892          3              1\n",
        "\n",
        "In multivariate analysis the risk of [[anaemia]] was significantly associated with [[zidovudine]] (OR, 3.27 95% CI, 1.64-6.54, P = 0.0008) and peg-IFN (OR, 2.35; 95% CI, 1.16-4.57, P = 0.0179).\n",
        "\n",
        "============================================================\n",
        "Unit id: 707284912\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_19       positive      2.4833          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_19  used_to_treat      2.4833          3              1\n",
        "\n",
        "The results from these studies, encompassing end points measuring lung function and symptoms, found that [[montelukast]] provided effective and beneficial [[asthma]] control to children aged 2 to 14 years with mild asthma.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124742\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_191       positive      2.5509          3        0.76832   \n",
        "1  drug_disease_191    speculative      0.7692          1        0.23168   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "1      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_191  used_to_treat      2.5509          3              1\n",
        "\n",
        "The risk of [[anaemia]] was lower in patients with higher baseline haemoglobin levels (OR, 0.35 95% CI, 0.26-0.49, P < 0.0001) and in patients receiving [[protease inhibitor]]-based antiretroviral therapy (OR, 0.51 95% CI, 0.30-0.86, P = 0.0114).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124716\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_192       positive      2.4221          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_192      may_cause      1.6948          2       0.699723\n",
        "1  drug_disease_192  used_to_treat      0.7273          1       0.300277\n",
        "\n",
        "The most frequent and the most troublesome adverse effect of interferon plus [[ribavirin]]-based therapy is [[anaemia]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124732\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_193       positive      2.4004          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_193  used_to_treat      2.4004          3              1\n",
        "\n",
        "This study demonstrated that both low-dose topiramate and [[propranolol]] could significantly reduce [[migraine headache]] frequency, intensity, and duration.\n",
        "\n",
        "============================================================\n",
        "Unit id: 707280277"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_194       positive      2.5879          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_194  used_to_treat      1.7308          2       0.668805\n",
        "0  drug_disease_194      may_cause      0.8571          1       0.331195\n",
        "\n",
        "This study demonstrated that both low-dose [[topiramate]] and propranolol could significantly reduce [[migraine headache]] frequency, intensity, and duration.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124916\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "1  drug_disease_195       positive      2.5483          3       0.759327   \n",
        "0  drug_disease_195          false      0.8077          1       0.240673   \n",
        "\n",
        "   match  \n",
        "1      1  \n",
        "0      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_195  used_to_treat      2.5483          3              1\n",
        "\n",
        "Results - The [[topiramate]] group showed a reduction in the mean (+/-SD) of monthly migraine frequency from 6.07 (+/-1.89) to 1.83 (+/-1.39) episodes per month, [[headache]] intensity from 7.1 (+/-1.45) to 3.67 (+/-2.1) based on the Visual Analog Scale, and headache duration from 16.37 (+/-7.26) to 6.23 (+/-5.22) hours (P < 0.001).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124710\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "1  drug_disease_196       positive      1.8517          2       0.706513   \n",
        "0  drug_disease_196       negative      0.7692          1       0.293487   \n",
        "\n",
        "   match  \n",
        "1      1  \n",
        "0      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_196  used_to_treat      1.8517          2              1\n",
        "\n",
        "Results - The [[topiramate]] group showed a reduction in the mean (+/-SD) of monthly [[migraine]] frequency from 6.07 (+/-1.89) to 1.83 (+/-1.39) episodes per month, headache intensity from 7.1 (+/-1.45) to 3.67 (+/-2.1) based on the Visual Analog Scale, and headache duration from 16.37 (+/-7.26) to 6.23 (+/-5.22) hours (P < 0.001).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124825\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_197       positive      2.5666          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_197      may_cause      2.5666          3              1\n",
        "\n",
        "Long-term exposure to [[medium-dose glucocorticoid]] therapy associates with [[hypertension]] in patients with rheumatoid arthritis.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124883\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_20       positive      2.6092          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_20  used_to_treat      2.6092          3              1\n",
        "\n",
        "This article reviewed recent results from randomized, double-blind studies of children with mild asthma treated with [[montelukast]], a leukotriene receptor antagonist that is approved for the treatment of asthma and [[allergic rhinitis]] in children and adults.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124796"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_201       positive      2.4696          3       0.749932   \n",
        "1  drug_disease_201    speculative      0.8235          1       0.250068   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "1      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_201  used_to_treat      2.4696          3              1\n",
        "\n",
        "Collectively, the cardiovascular benefit, metabolic neutrality and homogeneous blood pressure response illuminated in recent studies, and reviewed here, represent a reaffirmation of the benefit of [[long-acting dihydropyridine calcium channel antagonists]] and should serve to help reinforce the critical importance of these agents in the therapeutic armamentarium against [[cardiovascular disease]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124844\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_204       positive      2.6696          3       0.766664   \n",
        "1  drug_disease_204    speculative      0.8125          1       0.233336   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "1      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_204  used_to_treat      2.6696          3              1\n",
        "\n",
        "Compared with both diuretics and contemporary agents, [[amlodipine]] decreases [[cardiovascular events]] to a similar or greater extent without evidence for increased coronary heart disease, gastrointestinal bleeding or cancer.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124678\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_206       positive      4.1178          5              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_206  used_to_treat      4.1178          5              1\n",
        "\n",
        "All three patients had recurrent admissions for stomal bleeding and [[stomal varices secondary to portal hypertension]] and were initially treated with local measures (pressure, [[silver nitrate]], and suture ligation).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124774\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_207       positive      2.4867          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_207  used_to_treat      2.4867          3              1\n",
        "\n",
        "All three patients had recurrent admissions for [[stomal bleeding]] and stomal varices secondary to portal hypertension and were initially treated with local measures (pressure, [[silver nitrate]], and suture ligation).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124855\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "2  drug_disease_208       positive      3.2009          4       0.436554   \n",
        "3  drug_disease_208    speculative      1.7647          2       0.240678   \n",
        "0  drug_disease_208          false      1.6333          2       0.222757   \n",
        "1  drug_disease_208       negative      0.7333          1       0.100011   \n",
        "\n",
        "   match  \n",
        "2      1  \n",
        "3      0  \n",
        "0      0  \n",
        "1      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_208  used_to_treat      3.2009          4              1"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "At all doses studied, febuxostat more effectively lowered and maintained serum urate levels <6.0 mg/dl than did [[allopurinol]] (300 or 100 mg) or placebo in subjects with hyperuricemia and [[gout]], including those with mild to moderately impaired renal function.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124863\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_209       positive      2.5879          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_209  used_to_treat      1.7308          2       0.668805\n",
        "0  drug_disease_209      may_cause      0.8571          1       0.331195\n",
        "\n",
        "At all doses studied, febuxostat more effectively lowered and maintained serum urate levels <6.0 mg/dl than did [[allopurinol]] (300 or 100 mg) or placebo in subjects with [[hyperuricemia]] and gout, including those with mild to moderately impaired renal function.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124811\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_21       positive      2.3788          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_21  used_to_treat      2.3788          3              1\n",
        "\n",
        "The combination of high-dose MTX with [[procarbazine]] and CCNU is feasible and effective and results in a low rate of [[leukoencephalopathy]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124748\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_210       positive      2.5845          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_210  used_to_treat      2.5845          3              1\n",
        "\n",
        "A significantly (P < 0.05) higher percentage of subjects with [[impaired renal function]] treated with [[febuxostat]] 80 mg (4 [44%] of 9), 120 mg (5 [45%] of 11), and 240 mg (3 [60%] of 5) achieved the primary end point compared with those treated with 100 mg of allopurinol (0 [0%] of 10).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124831\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_211       positive      2.4999          3       0.753413   \n",
        "1  drug_disease_211    speculative      0.8182          1       0.246587   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "1      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_211      may_cause      1.6666          2       0.666667\n",
        "1  drug_disease_211  used_to_treat      0.8333          1       0.333333\n",
        "\n",
        "The primary reasons for withdrawal were similar across groups except for [[gout flares]], which were more frequent with febuxostat than with [[allopurinol]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124730\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_212       positive      2.4221          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  "
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_212  used_to_treat      2.4221          3              1\n",
        "\n",
        "At all doses studied, [[febuxostat]] more effectively lowered and maintained serum urate levels <6.0 mg/dl than did allopurinol (300 or 100 mg) or placebo in subjects with hyperuricemia and [[gout]], including those with mild to moderately impaired renal function.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124856\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_213       positive      1.6648          2       0.689415   \n",
        "1  drug_disease_213    speculative      0.7500          1       0.310585   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "1      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_213          other      0.8571          1       0.514837\n",
        "1  drug_disease_213  used_to_treat      0.8077          1       0.485163\n",
        "\n",
        "At all doses studied, [[febuxostat]] more effectively lowered and maintained serum urate levels <6.0 mg/dl than did allopurinol (300 or 100 mg) or placebo in subjects with hyperuricemia and gout, including those with mild to moderately [[impaired renal function]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124789\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_214       positive      2.5598          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_214  used_to_treat      2.5598          3              1\n",
        "\n",
        "At all doses studied, [[febuxostat]] more effectively lowered and maintained serum urate levels <6.0 mg/dl than did allopurinol (300 or 100 mg) or placebo in subjects with [[hyperuricemia]] and gout, including those with mild to moderately impaired renal function.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124723\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "2  drug_disease_215       positive      5.2462          6       0.690190   \n",
        "1  drug_disease_215       negative      1.5549          2       0.204562   \n",
        "0  drug_disease_215          false      0.8000          1       0.105248   \n",
        "\n",
        "   match  \n",
        "2      1  \n",
        "1      0  \n",
        "0      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_215  used_to_treat      5.2462          6              1\n",
        "\n",
        "A significantly (P < 0.05) higher percentage of subjects with [[impaired renal function]] treated with febuxostat 80 mg (4 [44%] of 9), 120 mg (5 [45%] of 11), and 240 mg (3 [60%] of 5) achieved the primary end point compared with those treated with 100 mg of [[allopurinol]] (0 [0%] of 10).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124815\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_216       positive      2.5078          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_216      may_cause      1.7745          2       0.707592\n",
        "1  drug_disease_216  used_to_treat      0.7333          1       0.292408\n",
        "\n",
        "The primary reasons for withdrawal were similar across groups except for [[gout flares]], which were more frequent with [[febuxostat]] than with allopurinol.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124906"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_217       positive      2.4833          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_217      may_cause      2.4833          3              1\n",
        "\n",
        "Proportions of subjects experiencing any adverse event or serious adverse event were similar across groups, although diarrhea and [[dizziness]] were more frequent in the [[febuxostat]] 240 mg group.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124814\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_218       positive      2.5078          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_218      may_cause      2.5078          3              1\n",
        "\n",
        "Proportions of subjects experiencing any adverse event or serious adverse event were similar across groups, although [[diarrhea]] and dizziness were more frequent in the [[febuxostat]] 240 mg group.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706694486\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_22       positive      2.4148          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_22  used_to_treat      1.6071          2       0.665521\n",
        "0  drug_disease_22      may_cause      0.8077          1       0.334479\n",
        "\n",
        "The combination of [[high-dose MTX]] with procarbazine and CCNU is feasible and effective and results in a low rate of [[leukoencephalopathy]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124728\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_220       positive      2.4221          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_220      may_cause      2.4221          3              1\n",
        "\n",
        "While the association between [[neural tube defects]] and [[antiepileptic drugs]] is well recognised, other congenital malformations are known to occur.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124767\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "1  drug_disease_221       positive      4.1666          5       0.543992   \n",
        "2  drug_disease_221    speculative      1.8745          2       0.244735   \n",
        "0  drug_disease_221          false      1.6182          2       0.211273   \n",
        "\n",
        "   match  \n",
        "1      1  \n",
        "2      0  \n",
        "0      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_221      may_cause      4.1666          5              1\n",
        "\n",
        "While the association between neural tube defects and [[antiepileptic drugs]] is well recognised, other [[congenital malformations]] are known to occur.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124871"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_224       positive        2.85          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_224  used_to_treat        2.85          3              1\n",
        "\n",
        "The patient was on corticosteroids and [[azathioprine]] for [[autoimmune hepatitis]] at the time of her presentation.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124734\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_225       positive      2.5589          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_225      may_cause      1.6498          2        0.64473\n",
        "1  drug_disease_225          other      0.9091          1        0.35527\n",
        "\n",
        "[[Pulmonary alveolar proteinosis]]: a rare pulmonary toxicity of [[sirolimus]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 707276727\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_226       positive      2.4148          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_226      may_cause      2.4148          3              1\n",
        "\n",
        "[[PAP]] is a very rare complication of [[SRL]] therapy with only a few cases described.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124837\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_23       positive      2.3778          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_23  used_to_treat      2.3778          3              1\n",
        "\n",
        "The combination of high-dose MTX with procarbazine and [[CCNU]] is feasible and effective and results in a low rate of [[leukoencephalopathy]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 707283394\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_230       positive      2.4148          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_230      may_cause      2.4148          3              1\n",
        "\n",
        "All patients converted to SRL because of [[GI side effects]] of [[MMF]] showed improvements, and none of those converted because of hyperglycemia experienced improvement.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124879"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_231       positive      2.4833          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_231  used_to_treat      1.7333          2       0.697983\n",
        "0  drug_disease_231      may_cause      0.7500          1       0.302017\n",
        "\n",
        "We concluded that conversion to SRL in pancreas transplantation should be considered an important alternative strategy, particularly for CNI nephrotoxicity and neurotoxicity, and in cases of [[severe diarrhea]] due to [[MMF]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 707780960\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "1  drug_disease_234       positive      2.8611          3       0.754032   \n",
        "0  drug_disease_234       negative      0.9333          1       0.245968   \n",
        "\n",
        "   match  \n",
        "1      1  \n",
        "0      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_234      may_cause      2.8611          3              1\n",
        "\n",
        "Moreover, [[oxcarbazepine]] can be a valid choice when long-term therapy is required because of the low interaction with other drugs and the low [[hematological side effects]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124779\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_236       positive      2.5598          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_236  used_to_treat      2.5598          3              1\n",
        "\n",
        "Our data showed that [[oxcarbazepine]] can be a good alternative to traditional antiepileptic agents in the prevention of [[perioperative seizures]] being efficacy, ease of use (rapid titration in 3 days, not requiring close plasma concentration monitoring) and good tolerability (no major side effects during titration and during the first postoperative week) the key factors.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124804\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "1  drug_disease_24       positive      2.5901          3       0.764019      1\n",
        "0  drug_disease_24          false      0.8000          1       0.235981      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_24  used_to_treat      2.5901          3              1\n",
        "\n",
        "[[Intra-articular injection of lidocaine]] before closed reduction of [[anterior shoulder dislocation]] produces the same pain relief as intravenous meperidine and diazepam.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124895\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_240       positive       2.609          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_240  used_to_treat      1.8398          2       0.705174\n",
        "0  drug_disease_240      may_cause      0.7692          1       0.294826\n",
        "\n",
        "Oral BDP prevents [[relapses of gastrointestinal GVHD]] following tapering of [[prednisone]]; survival is statistically significantly better among patients receiving BDP.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124840"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_241       positive      2.4848          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_241  used_to_treat      2.4848          3              1\n",
        "\n",
        "Oral BDP prevents [[relapses of gastrointestinal GVHD]] following tapering of prednisone; survival is statistically significantly better among patients receiving [[BDP]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124736\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_242       positive      2.4004          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_242      may_cause      2.4004          3              1\n",
        "\n",
        "Grade 3 or 4 leukopenia and [[edema]] and various grade 1 or 2 adverse events were more frequent in patients receiving eight [[TAC]] cycles than in those receiving six cycles.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124697\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_243       positive       2.397          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_243      may_cause       2.397          3              1\n",
        "\n",
        "Grade 3 or 4 [[leukopenia]] and edema and various grade 1 or 2 adverse events were more frequent in patients receiving eight [[TAC]] cycles than in those receiving six cycles.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124874\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_25       positive      2.6092          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_25  used_to_treat      1.8015          2       0.690442\n",
        "0  drug_disease_25      may_cause      0.8077          1       0.309558\n",
        "\n",
        "Intra-articular injection of lidocaine before closed reduction of anterior shoulder dislocation produces the same [[pain]] relief as [[intravenous meperidine]] and diazepam.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124846\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "1  drug_disease_26       positive      1.7594          2       0.707524      1\n",
        "0  drug_disease_26          false      0.7273          1       0.292476      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_26  used_to_treat      0.9412          1       0.534955\n",
        "0  drug_disease_26          other      0.8182          1       0.465045\n",
        "\n",
        "Intra-articular injection of lidocaine before closed reduction of anterior shoulder dislocation produces the same [[pain]] relief as intravenous meperidine and [[diazepam]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124798"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_27       positive      2.3788          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_27  used_to_treat      1.6515          2       0.694258\n",
        "0  drug_disease_27          other      0.7273          1       0.305742\n",
        "\n",
        "Intra-articular injection of lidocaine before closed reduction of [[anterior shoulder dislocation]] produces the same pain relief as intravenous meperidine and [[diazepam]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124870\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_28       positive       2.609          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_28  used_to_treat       2.609          3              1\n",
        "\n",
        "Intra-articular injection of lidocaine before closed reduction of [[anterior shoulder dislocation]] produces the same pain relief as [[intravenous meperidine]] and diazepam.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124726\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "1  drug_disease_29       positive      2.5971          3       0.757084      1\n",
        "0  drug_disease_29          false      0.8333          1       0.242916      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_29  used_to_treat      1.6559          2       0.637596\n",
        "0  drug_disease_29      may_cause      0.9412          1       0.362404\n",
        "\n",
        "Mean [[pain]] (mm) recorded before injection, before reduction, and after reduction in the [[intra-articular lidocaine]] group was 84.3 (95% confidence interval (CI) 79.8 to 88.8), 52.6 (95% CI 45.2 to 60.1), and 27.3 (95% CI 19.9 to 34.7), respectively.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124698\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_30       positive      2.4686          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_30  used_to_treat      1.6504          2       0.668557\n",
        "0  drug_disease_30      may_cause      0.8182          1       0.331443\n",
        "\n",
        "[[Intra-articular injection of lidocaine]] before closed reduction of anterior shoulder dislocation produces the same [[pain]] relief as intravenous meperidine and diazepam.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124910\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_32       positive      2.6836          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_32  used_to_treat      1.8503          2       0.689484\n",
        "0  drug_disease_32      may_cause      0.8333          1       0.310516\n",
        "\n",
        "Another important finding was that the cytotoxic effect induced by 25 microM or 50 microM of [[indomethacin-loaded nanocapsules]] or indomethacin ethyl ester-loaded nanocapsules, in [[glioma]] cells was not observed in the organotypic cultures, indicating selective cytotoxicity of those formulations for tumoral cells.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124706"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_33       positive      3.9401          5       0.536703      1\n",
        "1  drug_disease_33    speculative      3.4012          4       0.463297      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_33  used_to_treat      3.1068          4       0.788508\n",
        "0  drug_disease_33      may_cause      0.8333          1       0.211492\n",
        "\n",
        "Selective cytotoxicity of [[indomethacin]] and indomethacin ethyl ester-loaded nanocapsules against [[glioma]] cell lines: an in vitro study.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124735\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_34       positive      2.7424          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_34  used_to_treat      2.7424          3              1\n",
        "\n",
        "The main finding of the present study is that [[indomethacin-loaded nanocapsules]] formulation was more potent than a solution of indomethacin in decreasing the viability and cell proliferation of [[glioma]] lines.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124713\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_35       positive      2.5455          3       0.764139      1\n",
        "1  drug_disease_35    speculative      0.7857          1       0.235861      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_35  used_to_treat      2.5455          3              1\n",
        "\n",
        "The main finding of the present study is that indomethacin-loaded nanocapsules formulation was more potent than a [[solution of indomethacin]] in decreasing the viability and cell proliferation of [[glioma]] lines.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124889\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_36       positive      2.6836          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_36  used_to_treat      1.8503          2       0.689484\n",
        "0  drug_disease_36      may_cause      0.8333          1       0.310516\n",
        "\n",
        "In addition, when the [[glioma]] cells were exposed to 25 microM of indomethacin-loaded nanocapsules or [[indomethacin ethyl ester-loaded nanocapsules]], a necrotic cell death was observed.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124783\n",
        "\n",
        "EU-ADR answer: false\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_37          false      3.1163          4       0.422023      1\n",
        "1  drug_disease_37       positive      2.5158          3       0.340700      0\n",
        "2  drug_disease_37    speculative      1.7521          2       0.237277      0\n",
        "\n",
        "Selective cytotoxicity of indomethacin and [[indomethacin ethyl ester-loaded nanocapsules]] against [[glioma]] cell lines: an in vitro study.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124806"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_38       positive      2.4245          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "2  drug_disease_38  used_to_treat      0.9412          1       0.388204\n",
        "0  drug_disease_38      may_cause      0.7500          1       0.309342\n",
        "1  drug_disease_38          other      0.7333          1       0.302454\n",
        "\n",
        "In addition, when the [[glioma]] cells were exposed to 25 microM of [[indomethacin-loaded nanocapsules]] or indomethacin ethyl ester-loaded nanocapsules, a necrotic cell death was observed.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124771\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "2  drug_disease_39       positive      3.3362          4       0.447092      1\n",
        "1  drug_disease_39       negative      2.5743          3       0.344988      0\n",
        "3  drug_disease_39    speculative      0.8182          1       0.109649      0\n",
        "0  drug_disease_39          false      0.7333          1       0.098271      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "2  drug_disease_39  used_to_treat      1.6904          2       0.506684\n",
        "1  drug_disease_39          other      0.8333          1       0.249775\n",
        "0  drug_disease_39      may_cause      0.8125          1       0.243541\n",
        "\n",
        "Another important finding was that the cytotoxic effect induced by 25 microM or 50 microM of indomethacin-loaded nanocapsules or [[indomethacin ethyl ester-loaded nanocapsules]], in [[glioma]] cells was not observed in the organotypic cultures, indicating selective cytotoxicity of those formulations for tumoral cells.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124733\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_42       positive      2.4892          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_42  used_to_treat      1.6559          2       0.665234\n",
        "0  drug_disease_42      may_cause      0.8333          1       0.334766\n",
        "\n",
        "Indomethacin and [[indomethacin ethyl ester]] associated together in the same nanocapsule formulation caused a synergic effect decreasing [[glioma]] cell proliferation.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124884\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_43       positive      2.3596          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_43  used_to_treat      2.3596          3              1\n",
        "\n",
        "[[Indomethacin]] and indomethacin ethyl ester associated together in the same nanocapsule formulation caused a synergic effect decreasing [[glioma]] cell proliferation.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124773\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "1  drug_disease_46       positive      2.5245          3       0.774909      1\n",
        "0  drug_disease_46          false      0.7333          1       0.225091      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_46  used_to_treat      2.5245          3              1"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "Quantification of circulating varicella-zoster virus DNA for follow-up in a case of [[visceral varicella-zoster infection]] ameliorated with [[intravenous acyclovir]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124853\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_47       positive      2.3778          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_47  used_to_treat      2.3778          3              1\n",
        "\n",
        "We describe a patient with acute lymphocytic leukemia (ALL) who developed [[visceral varicella-zoster virus]] (VZV) infection following cord blood stem cell transplantation (CBSCT) and was successfully treated with [[intravenous acyclovir]] (ACV).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124807\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_48       positive      2.5078          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_48  used_to_treat      2.5078          3              1\n",
        "\n",
        "We describe a patient with acute lymphocytic leukemia (ALL) who developed visceral varicella-zoster virus ([[VZV) infection]] following cord blood stem cell transplantation (CBSCT) and was successfully treated with [[intravenous acyclovir]] (ACV).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124704\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "       pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_5       positive       2.397          3              1      1\n",
        "\n",
        "       pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_5      may_cause       2.397          3              1\n",
        "\n",
        "However, decreased tear production after [[botulinum toxin]] injection for crow's feet is a possible complication and patients should be advised of the small but definite risk of a temporary [[dry eye]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124707\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_50       positive      2.4004          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_50  used_to_treat      1.6504          2       0.687552\n",
        "0  drug_disease_50      may_cause      0.7500          1       0.312448\n",
        "\n",
        "Although the role of [[clozapine]] is well established for [[treatment-resistant schizophrenia]], it is rarely used in pediatric populations, mainly due to its potentially serious adverse effects.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124893\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_51       positive      2.3596          3              1      1"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_51  used_to_treat      2.3596          3              1\n",
        "\n",
        "To summarize practical aspects of use of [[clozapine]] in treating children with [[schizophrenia]] and management of associated adverse effects.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124747\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_52       positive      2.5564          3       0.737671      1\n",
        "1  drug_disease_52    speculative      0.9091          1       0.262329      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_52  used_to_treat      2.5564          3              1\n",
        "\n",
        "Despite a higher incidence of adverse effects in children, [[clozapine]] appears to be a uniquely beneficial second-line agent for treating children with [[refractory schizophrenia]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124854\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_53       positive      2.5598          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_53      may_cause      2.5598          3              1\n",
        "\n",
        "[[Keratoacanthoma]] occurring within the [[red dye of a tattoo]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 707285195\n",
        "\n",
        "EU-ADR answer: speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_55    speculative      2.6836          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_55      may_cause      2.6836          3              1\n",
        "\n",
        "Information from the SITE Cohort Study should clarify whether use of these [[immunosuppressive drugs]] for ocular inflammation increases the risk of mortality and [[fatal cancer]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124696\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_56       positive      2.7424          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_56      may_cause      1.7424          2       0.635356\n",
        "1  drug_disease_56  used_to_treat      1.0000          1       0.364644\n",
        "\n",
        "Calculated detectable differences for mortality/[[fatal malignancy]] with respect to the general population are 22%/49% for [[antimetabolites]], 28%/62% for T-cell inhibitors, and 36%/81% for alkylating agents.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124682"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_59       positive       2.397          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_59      may_cause      1.6113          2       0.672215\n",
        "1  drug_disease_59  used_to_treat      0.7857          1       0.327785\n",
        "\n",
        "Calculated detectable differences for mortality/[[fatal malignancy]] with respect to the general population are 22%/49% for antimetabolites, 28%/62% for [[T-cell inhibitors]], and 36%/81% for alkylating agents.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124908\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "       pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_6       positive        2.85          3              1      1\n",
        "\n",
        "       pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_6  used_to_treat        2.85          3              1\n",
        "\n",
        "[[Botulinum toxins]] are potent neurotoxins used in a variety of [[neurological disorders]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124841\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "1  drug_disease_62       positive      3.4887          4       0.469846      1\n",
        "0  drug_disease_62          false      3.1240          4       0.420729      0\n",
        "2  drug_disease_62    speculative      0.8125          1       0.109425      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_62      may_cause      3.4887          4              1\n",
        "\n",
        "Calculated detectable differences for mortality/[[fatal malignancy]] with respect to the general population are 22%/49% for antimetabolites, 28%/62% for T-cell inhibitors, and 36%/81% for [[alkylating agents]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124899\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_63       positive      2.3596          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_63      may_cause      1.5025          2        0.63676\n",
        "1  drug_disease_63  used_to_treat      0.8571          1        0.36324\n",
        "\n",
        "There were consistent significant [[miosis]] in the right eyes with instilled [[Garcinia kola nut extract]] compared to the left eyes at 15, 30 and 45 minutes (p=0.0000).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124782\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "2  drug_disease_64       positive      4.1098          5       0.556567      1\n",
        "0  drug_disease_64          false      2.4619          3       0.333401      0\n",
        "1  drug_disease_64       negative      0.8125          1       0.110032      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_64          other      3.2636          4       0.794102\n",
        "1  drug_disease_64  used_to_treat      0.8462          1       0.205898"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "There is evidence in the literature that inhaled corticosteroids ([[ICSs]]) are safe for pregnant women with [[asthma]] and their infants.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124684\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "2  drug_disease_65       positive      4.2677          5       0.556589      1\n",
        "1  drug_disease_65       negative      2.5999          3       0.339076      0\n",
        "0  drug_disease_65          false      0.8000          1       0.104335      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_65  used_to_treat      4.2677          5              1\n",
        "\n",
        "There is evidence in the literature that [[inhaled corticosteroids]] (ICSs) are safe for pregnant women with [[asthma]] and their infants.\n",
        "\n",
        "============================================================\n",
        "Unit id: 707283605\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_69       positive       2.609          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_69  used_to_treat       2.609          3              1\n",
        "\n",
        "[[5-aminosalicylic acid]] inhibits [[colitis-associated colorectal dysplasias]] in the mouse model of azoxymethane/dextran sulfate sodium-induced colitis.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124892\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "       pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_7       positive      2.6836          3              1      1\n",
        "\n",
        "       pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_7  used_to_treat      1.8503          2       0.689484\n",
        "0  drug_disease_7      may_cause      0.8333          1       0.310516\n",
        "\n",
        "We describe the case of a 10-year-old boy who developed systemic weakness following treatment of [[spasticity]] with [[botulinum toxin type B]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124802\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_70       positive      2.4245          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_70      may_cause      2.4245          3              1\n",
        "\n",
        "The chemopreventive activity of 5-ASA was evaluated in the Swiss Webster model of azoxymethane (AOM)/[[dextran sulfate sodium]] (DSS)-induced [[colitis-associated neoplasia]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 707283108\n",
        "\n",
        "EU-ADR answer: speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "1  drug_disease_71    speculative      1.7333          2       0.697983      1\n",
        "0  drug_disease_71       positive      0.7500          1       0.302017      0"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_71  used_to_treat      1.7333          2              1\n",
        "\n",
        "These data suggest that [[low-dose 5-ASA]] may be efficacious in preventing [[colitis-associated dysplasias]] and provide strong support for optimizing this therapy for the prevention of colonic neoplasms in patients with ulcerative colitis.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124904\n",
        "\n",
        "EU-ADR answer: speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "1  drug_disease_72    speculative      4.3107          5       0.567773      1\n",
        "0  drug_disease_72       positive      3.2816          4       0.432227      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_72  used_to_treat      4.3107          5              1\n",
        "\n",
        "These data suggest that [[low-dose 5-ASA]] may be efficacious in preventing colitis-associated dysplasias and provide strong support for optimizing this therapy for the prevention of [[colonic neoplasms]] in patients with ulcerative colitis.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124762\n",
        "\n",
        "EU-ADR answer: speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "3  drug_disease_73    speculative      4.1809          5       0.540342      1\n",
        "2  drug_disease_73       positive      1.8643          2       0.240943      0\n",
        "0  drug_disease_73          false      0.9231          1       0.119302      0\n",
        "1  drug_disease_73       negative      0.7692          1       0.099412      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_73  used_to_treat      4.1809          5              1\n",
        "\n",
        "These data suggest that [[low-dose 5-ASA]] may be efficacious in preventing colitis-associated dysplasias and provide strong support for optimizing this therapy for the prevention of colonic neoplasms in patients with [[ulcerative colitis]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 707278758\n",
        "\n",
        "EU-ADR answer: speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "1  drug_disease_74    speculative      1.8398          2       0.705174      1\n",
        "0  drug_disease_74       positive      0.7692          1       0.294826      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_74      may_cause      0.9231          1       0.501739\n",
        "1  drug_disease_74  used_to_treat      0.9167          1       0.498261\n",
        "\n",
        "The impact of the antiinflammatory agent 5-aminosalicylic acid ([[5-ASA]]) on the risk for [[colitis-associated colorectal cancer]] remains controversial.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124843\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_77       positive      2.3034          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_77  used_to_treat      2.3034          3              1\n",
        "\n",
        "Administration of 75 mg/kg [[5-ASA]] decreased both the mean multiplicity of flat dysplasias (1.8 +/- 0.4 for drug-treated versus 5.6 +/- 1.2 for AOM/DSS control) and the burden of polypoid dysplasias ([[tumor]] burden: 6.7 +/- 2.7 for drug-treated versus 14.9 +/- 3.9 units for AOM/DSS controls) significantly (P = 0.002 and 0.04, respectively).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124780"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "1  drug_disease_78       positive      2.5245          3       0.774909      1\n",
        "0  drug_disease_78          false      0.7333          1       0.225091      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_78      may_cause      1.6912          2       0.669915\n",
        "1  drug_disease_78  used_to_treat      0.8333          1       0.330085\n",
        "\n",
        "An inverse trend was observed between dose and multiplicity of colonic dysplasias in all drug-treated groups (P = 0.03), with animals receiving 75 mg/kg [[5-ASA]] exhibiting 56% of the number of [[dysplasias]] of the AOM/DSS controls (mean +/- SEM: 7.6 +/- 1.4 and 13.6 +/- 2.7, respectively).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124738\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_79       positive      2.7424          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_79  used_to_treat      2.7424          3              1\n",
        "\n",
        "Administration of 75 mg/kg [[5-ASA]] decreased both the mean multiplicity of [[flat dysplasias]] (1.8 +/- 0.4 for drug-treated versus 5.6 +/- 1.2 for AOM/DSS control) and the burden of polypoid dysplasias (tumor burden: 6.7 +/- 2.7 for drug-treated versus 14.9 +/- 3.9 units for AOM/DSS controls) significantly (P = 0.002 and 0.04, respectively).\n",
        "\n",
        "============================================================\n",
        "Unit id: 707287494\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "       pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_8       positive      2.3596          3              1      1\n",
        "\n",
        "       pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_8      may_cause      2.3596          3              1\n",
        "\n",
        "We describe the case of a 10-year-old boy who developed [[systemic weakness]] following treatment of spasticity with [[botulinum toxin type B]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124915\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_81       positive      2.6092          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_81      may_cause      1.8015          2       0.690442\n",
        "1  drug_disease_81  used_to_treat      0.8077          1       0.309558\n",
        "\n",
        "An inverse trend was observed between dose and multiplicity of [[colonic dysplasias]] in all drug-treated groups (P = 0.03), with animals receiving 75 mg/kg [[5-ASA]] exhibiting 56% of the number of dysplasias of the AOM/DSS controls (mean +/- SEM: 7.6 +/- 1.4 and 13.6 +/- 2.7, respectively).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124822\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_82       positive      2.3788          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_82      may_cause      1.6515          2       0.694258\n",
        "1  drug_disease_82          other      0.7273          1       0.305742"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "[[Spinal cord infarction]] secondary to [[cocaine]] use.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124849\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_83       positive      2.5983          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_83      may_cause      2.5983          3              1\n",
        "\n",
        "[[Cocaine]] abuse is associated with [[cerebrovascular events]]; spinal cord effects are rarely reported.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124731\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_84       positive       2.397          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_84      may_cause       2.397          3              1\n",
        "\n",
        "Although uncommon, [[cocaine]] abuse can cause [[spinal cord infarction]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 707004997\n",
        "\n",
        "EU-ADR answer: speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_85    speculative      2.5421          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_85      may_cause      2.5421          3              1\n",
        "\n",
        "We report two rheumatoid arthritis patients developing [[sarcoidosis]] possibly induced by [[etanercept]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124861\n",
        "\n",
        "EU-ADR answer: speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_90    speculative      2.3596          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_90          other      1.5904          2       0.674013\n",
        "0  drug_disease_90      may_cause      0.7692          1       0.325987\n",
        "\n",
        "Furthermore, there may be a relationship between [[statin]] dose and [[cancer]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124891\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_93       positive       2.609          3              1      1"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_93  used_to_treat       2.609          3              1\n",
        "\n",
        "[[BiRD]] is an effective regimen with manageable side effects in the treatment of symptomatic, newly diagnosed [[multiple myeloma]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124850\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "1  drug_disease_95       positive      4.9582          6       0.668672      1\n",
        "2  drug_disease_95    speculative      1.6568          2       0.223439      0\n",
        "0  drug_disease_95          false      0.8000          1       0.107889      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_95  used_to_treat      4.1011          5       0.827135\n",
        "0  drug_disease_95          other      0.8571          1       0.172865\n",
        "\n",
        "A multipronged approach to limit [[endophthalmitis]] risk is also needed, with [[antibiotics]] as only part of the strategy.\n",
        "\n",
        "============================================================\n",
        "Unit id: 707286886\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_96       positive      2.5126          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_96  used_to_treat      2.5126          3              1\n",
        "\n",
        "In this study, a 2-year-old girl with [[nephropathic cystinosis]] and severe gastrointestinal dysmotility was treated with intravenous ([[i.v.) administration of cysteamine hydrochloride]] (HCl).\n",
        "\n",
        "============================================================\n",
        "Unit id: 707283447\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_97       positive        2.85          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_97      may_cause        2.85          3              1\n",
        "\n",
        "The most common adverse effects associated with the use of [[posaconazole]] include headache, fever, nausea, vomiting, and [[diarrhea]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124817\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_98       positive      2.4564          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_98  used_to_treat      2.4564          3              1\n",
        "\n",
        "[[Posaconazole]] is noninferior to fluconazole for treatment of [[oropharyngeal candidiasis]] (95% CI -6.6 to 5.0), but necessity for this indication remains unclear, as many other treatment options exist.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124681"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "2  drug_disease_99       positive      4.4928          5       0.589367      1\n",
        "0  drug_disease_99          false      1.6278          2       0.213535      0\n",
        "1  drug_disease_99       negative      1.5025          2       0.197098      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_99  used_to_treat      4.4928          5              1\n",
        "\n",
        "Similarly, the same regimen of posaconazole reduced invasive fungal infections (95% CI -9.7 to -2.5) and [[aspergillosis]] (CI not reported, p < 0.001) when compared with fluconazole and [[itraconazole]] in neutropenic patients.\n",
        "\n",
        "============================================================\n"
       ]
      }
     ],
     "prompt_number": 21
    },
    {
     "cell_type": "markdown",
     "metadata": {},
     "source": [
      "Deep semantics agreement percentage for top choice:"
     ]
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "temp = []\n",
      "for rel_id, group in deep_sem_res.groupby(\"pub_rel_id\"):\n",
      "    temp.append(group.iloc[0][\"percent_agree\"])\n",
      "    \n",
      "graph = pd.Series(sorted(temp)).plot()\n",
      "graph.set_ylim((0, 1.1))\n",
      "    "
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 25,
       "text": [
        "(0, 1.1)"
       ]
      },
      {
       "metadata": {},
       "output_type": "display_data",
       "png": "iVBORw0KGgoAAAANSUhEUgAAAXgAAAD7CAYAAABgzo9kAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\ngwAAAABJRU5ErkJggg==\n",
       "text": [
        "<matplotlib.figure.Figure at 0x7ffa5f5ca650>"
       ]
      }
     ],
     "prompt_number": 25
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "temp = []\n",
      "for rel_id, group in deep_sem_res.groupby(\"pub_rel_id\"):\n",
      "    if group.iloc[0][\"percent_agree\"] < 0.8:\n",
      "        temp.append((rel_id, group.iloc[0][\"percent_agree\"]))\n",
      "        \n",
      "temp = sorted(temp, key = lambda x: x[1])\n",
      "\n",
      "\n",
      "summary(map(lambda x: x[0], temp))"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "Unit id: 706124806\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_38       positive      2.4245          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "2  drug_disease_38  used_to_treat      0.9412          1       0.388204\n",
        "0  drug_disease_38      may_cause      0.7500          1       0.309342\n",
        "1  drug_disease_38          other      0.7333          1       0.302454\n",
        "\n",
        "In addition, when the [[glioma]] cells were exposed to 25 microM of [[indomethacin-loaded nanocapsules]] or indomethacin ethyl ester-loaded nanocapsules, a necrotic cell death was observed.\n",
        "\n",
        "============================================================\n",
        "Unit id: 707278758\n",
        "\n",
        "EU-ADR answer: speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "1  drug_disease_74    speculative      1.8398          2       0.705174      1\n",
        "0  drug_disease_74       positive      0.7692          1       0.294826      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_74      may_cause      0.9231          1       0.501739\n",
        "1  drug_disease_74  used_to_treat      0.9167          1       0.498261\n",
        "\n",
        "The impact of the antiinflammatory agent 5-aminosalicylic acid ([[5-ASA]]) on the risk for [[colitis-associated colorectal cancer]] remains controversial.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124771\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "2  drug_disease_39       positive      3.3362          4       0.447092      1\n",
        "1  drug_disease_39       negative      2.5743          3       0.344988      0\n",
        "3  drug_disease_39    speculative      0.8182          1       0.109649      0\n",
        "0  drug_disease_39          false      0.7333          1       0.098271      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "2  drug_disease_39  used_to_treat      1.6904          2       0.506684\n",
        "1  drug_disease_39          other      0.8333          1       0.249775\n",
        "0  drug_disease_39      may_cause      0.8125          1       0.243541\n",
        "\n",
        "Another important finding was that the cytotoxic effect induced by 25 microM or 50 microM of indomethacin-loaded nanocapsules or [[indomethacin ethyl ester-loaded nanocapsules]], in [[glioma]] cells was not observed in the organotypic cultures, indicating selective cytotoxicity of those formulations for tumoral cells.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124912\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_168       positive      1.6648          2       0.689415   \n",
        "1  drug_disease_168    speculative      0.7500          1       0.310585   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "1      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_168  used_to_treat      0.8571          1       0.514837\n",
        "0  drug_disease_168      may_cause      0.8077          1       0.485163\n",
        "\n",
        "To determine [[cancer]] risk in a cohort of 459 rheumatoid arthritis (RA) patients treated with [[methotrexate]] in community practice.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124856\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_213       positive      1.6648          2       0.689415   \n",
        "1  drug_disease_213    speculative      0.7500          1       0.310585   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "1      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_213          other      0.8571          1       0.514837\n",
        "1  drug_disease_213  used_to_treat      0.8077          1       0.485163"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "At all doses studied, [[febuxostat]] more effectively lowered and maintained serum urate levels <6.0 mg/dl than did allopurinol (300 or 100 mg) or placebo in subjects with hyperuricemia and gout, including those with mild to moderately [[impaired renal function]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124917\n",
        "\n",
        "EU-ADR answer: speculative\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "1  drug_disease_115    speculative      4.8437          6       0.655733   \n",
        "0  drug_disease_115       positive      2.5430          3       0.344267   \n",
        "\n",
        "   match  \n",
        "1      1  \n",
        "0      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_115  used_to_treat      2.5165          3       0.519541\n",
        "0  drug_disease_115      may_cause      2.3272          3       0.480459\n",
        "\n",
        "While some beneficial neuromotor effects of succimer therapy were observed in the present study there remains several unanswered questions such as how long these effects will persist and how [[succimer]] therapy modifies lead-associated [[cerebellar deficits]] manifesting as perturbations in vestibular and/or proprioception systems for postural balance and functional locomotion.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124846\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "1  drug_disease_26       positive      1.7594          2       0.707524      1\n",
        "0  drug_disease_26          false      0.7273          1       0.292476      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_26  used_to_treat      0.9412          1       0.534955\n",
        "0  drug_disease_26          other      0.8182          1       0.465045\n",
        "\n",
        "Intra-articular injection of lidocaine before closed reduction of anterior shoulder dislocation produces the same [[pain]] relief as intravenous meperidine and [[diazepam]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124696\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_56       positive      2.7424          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_56      may_cause      1.7424          2       0.635356\n",
        "1  drug_disease_56  used_to_treat      1.0000          1       0.364644\n",
        "\n",
        "Calculated detectable differences for mortality/[[fatal malignancy]] with respect to the general population are 22%/49% for [[antimetabolites]], 28%/62% for T-cell inhibitors, and 36%/81% for alkylating agents.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124899\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_63       positive      2.3596          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_63      may_cause      1.5025          2        0.63676\n",
        "1  drug_disease_63  used_to_treat      0.8571          1        0.36324\n",
        "\n",
        "There were consistent significant [[miosis]] in the right eyes with instilled [[Garcinia kola nut extract]] compared to the left eyes at 15, 30 and 45 minutes (p=0.0000).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124726"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "1  drug_disease_29       positive      2.5971          3       0.757084      1\n",
        "0  drug_disease_29          false      0.8333          1       0.242916      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_29  used_to_treat      1.6559          2       0.637596\n",
        "0  drug_disease_29      may_cause      0.9412          1       0.362404\n",
        "\n",
        "Mean [[pain]] (mm) recorded before injection, before reduction, and after reduction in the [[intra-articular lidocaine]] group was 84.3 (95% confidence interval (CI) 79.8 to 88.8), 52.6 (95% CI 45.2 to 60.1), and 27.3 (95% CI 19.9 to 34.7), respectively.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124734\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_225       positive      2.5589          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_225      may_cause      1.6498          2        0.64473\n",
        "1  drug_disease_225          other      0.9091          1        0.35527\n",
        "\n",
        "[[Pulmonary alveolar proteinosis]]: a rare pulmonary toxicity of [[sirolimus]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124821\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_113       positive      2.4848          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_113  used_to_treat      1.6515          2       0.664641\n",
        "0  drug_disease_113      may_cause      0.8333          1       0.335359\n",
        "\n",
        "Posaconazole, in doses of 200 mg 3 times daily, reduced breakthrough [[invasive fungal infections]] (OR 0.30; 95% CI 0.12 to 0.71) and aspergillosis incidence (OR 0.31; 95% CI 0.13 to 0.75) in patients receiving hematopoietic stem-cell transplants compared with those receiving [[fluconazole]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124721\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_170       positive      2.4892          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_170      may_cause      1.6559          2       0.665234\n",
        "1  drug_disease_170  used_to_treat      0.8333          1       0.334766\n",
        "\n",
        "Incidence of [[melanoma]] and other malignancies among rheumatoid arthritis patients treated with [[methotrexate]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124733\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_42       positive      2.4892          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_42  used_to_treat      1.6559          2       0.665234\n",
        "0  drug_disease_42      may_cause      0.8333          1       0.334766"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "Indomethacin and [[indomethacin ethyl ester]] associated together in the same nanocapsule formulation caused a synergic effect decreasing [[glioma]] cell proliferation.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706694486\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_22       positive      2.4148          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_22  used_to_treat      1.6071          2       0.665521\n",
        "0  drug_disease_22      may_cause      0.8077          1       0.334479\n",
        "\n",
        "The combination of [[high-dose MTX]] with procarbazine and CCNU is feasible and effective and results in a low rate of [[leukoencephalopathy]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124831\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_211       positive      2.4999          3       0.753413   \n",
        "1  drug_disease_211    speculative      0.8182          1       0.246587   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "1      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_211      may_cause      1.6666          2       0.666667\n",
        "1  drug_disease_211  used_to_treat      0.8333          1       0.333333\n",
        "\n",
        "The primary reasons for withdrawal were similar across groups except for [[gout flares]], which were more frequent with febuxostat than with [[allopurinol]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124698\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_30       positive      2.4686          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_30  used_to_treat      1.6504          2       0.668557\n",
        "0  drug_disease_30      may_cause      0.8182          1       0.331443\n",
        "\n",
        "[[Intra-articular injection of lidocaine]] before closed reduction of anterior shoulder dislocation produces the same [[pain]] relief as intravenous meperidine and diazepam.\n",
        "\n",
        "============================================================\n",
        "Unit id: 707280277\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_194       positive      2.5879          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_194  used_to_treat      1.7308          2       0.668805\n",
        "0  drug_disease_194      may_cause      0.8571          1       0.331195\n",
        "\n",
        "This study demonstrated that both low-dose [[topiramate]] and propranolol could significantly reduce [[migraine headache]] frequency, intensity, and duration.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124863\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_209       positive      2.5879          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  "
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_209  used_to_treat      1.7308          2       0.668805\n",
        "0  drug_disease_209      may_cause      0.8571          1       0.331195\n",
        "\n",
        "At all doses studied, febuxostat more effectively lowered and maintained serum urate levels <6.0 mg/dl than did [[allopurinol]] (300 or 100 mg) or placebo in subjects with [[hyperuricemia]] and gout, including those with mild to moderately impaired renal function.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124780\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "1  drug_disease_78       positive      2.5245          3       0.774909      1\n",
        "0  drug_disease_78          false      0.7333          1       0.225091      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_78      may_cause      1.6912          2       0.669915\n",
        "1  drug_disease_78  used_to_treat      0.8333          1       0.330085\n",
        "\n",
        "An inverse trend was observed between dose and multiplicity of colonic dysplasias in all drug-treated groups (P = 0.03), with animals receiving 75 mg/kg [[5-ASA]] exhibiting 56% of the number of [[dysplasias]] of the AOM/DSS controls (mean +/- SEM: 7.6 +/- 1.4 and 13.6 +/- 2.7, respectively).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124682\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_59       positive       2.397          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_59      may_cause      1.6113          2       0.672215\n",
        "1  drug_disease_59  used_to_treat      0.7857          1       0.327785\n",
        "\n",
        "Calculated detectable differences for mortality/[[fatal malignancy]] with respect to the general population are 22%/49% for antimetabolites, 28%/62% for [[T-cell inhibitors]], and 36%/81% for alkylating agents.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124861\n",
        "\n",
        "EU-ADR answer: speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_90    speculative      2.3596          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_90          other      1.5904          2       0.674013\n",
        "0  drug_disease_90      may_cause      0.7692          1       0.325987\n",
        "\n",
        "Furthermore, there may be a relationship between [[statin]] dose and [[cancer]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124794\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_154       positive      2.4745          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_154  used_to_treat      1.6745          2       0.676702\n",
        "0  drug_disease_154      may_cause      0.8000          1       0.323298\n",
        "\n",
        "Administration of full-dose R-CHOP (rituximab/cyclophosphamide/doxorubicin/vincristine/[[prednisone]]) chemotherapy is important to maximize response in patients with intermediate-or [[high-grade non-Hodgkin lymphoma]] but might be difficult in older patients.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124740"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_151       positive       2.397          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_151  used_to_treat      1.6278          2       0.679099\n",
        "0  drug_disease_151      may_cause      0.7692          1       0.320901\n",
        "\n",
        "Plasma [[ziprasidone]] levels ranged from 20 ng/mL to 160 ng/mL (mean: 75.8 ng/mL) and were significantly related to the improvement in [[negative symptoms]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124812\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_145       positive      2.5873          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_145  used_to_treat      1.7748          2       0.685966\n",
        "0  drug_disease_145      may_cause      0.8125          1       0.314034\n",
        "\n",
        "Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with [[PTCL]] received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, [[adriamycin]] 90 mg/m(2)/day, vincristine and prednisone alternating with three courses of etoposide, cisplatin, cytarabine and prednisone.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124820\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_147       positive      2.5873          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_147  used_to_treat      1.7748          2       0.685966\n",
        "0  drug_disease_147      may_cause      0.8125          1       0.314034\n",
        "\n",
        "Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with [[PTCL]] received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, adriamycin 90 mg/m(2)/day, vincristine and prednisone alternating with three courses of etoposide, cisplatin, cytarabine and [[prednisone]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124707\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_50       positive      2.4004          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_50  used_to_treat      1.6504          2       0.687552\n",
        "0  drug_disease_50      may_cause      0.7500          1       0.312448\n",
        "\n",
        "Although the role of [[clozapine]] is well established for [[treatment-resistant schizophrenia]], it is rarely used in pediatric populations, mainly due to its potentially serious adverse effects.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124828\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_169       positive      2.5666          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_169      may_cause      1.7666          2       0.688304\n",
        "1  drug_disease_169  used_to_treat      0.8000          1       0.311696\n",
        "\n",
        "Incidence of melanoma and other [[malignancies]] among rheumatoid arthritis patients treated with [[methotrexate]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124719"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_141       positive      2.6754          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_141  used_to_treat      1.8421          2       0.688533\n",
        "0  drug_disease_141      may_cause      0.8333          1       0.311467\n",
        "\n",
        "An open multicenter phase II trial of weekly [[docetaxel]] for [[advanced-stage non-small-cell lung cancer]] in elderly patients with significant comorbidity and/or poor performance status: The GFPC 02-02b study.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124894\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_167       positive      2.6836          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_167  used_to_treat      1.8503          2       0.689484\n",
        "0  drug_disease_167      may_cause      0.8333          1       0.310516\n",
        "\n",
        "To determine cancer risk in a cohort of 459 [[rheumatoid arthritis]] (RA) patients treated with [[methotrexate]] in community practice.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124910\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_32       positive      2.6836          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_32  used_to_treat      1.8503          2       0.689484\n",
        "0  drug_disease_32      may_cause      0.8333          1       0.310516\n",
        "\n",
        "Another important finding was that the cytotoxic effect induced by 25 microM or 50 microM of [[indomethacin-loaded nanocapsules]] or indomethacin ethyl ester-loaded nanocapsules, in [[glioma]] cells was not observed in the organotypic cultures, indicating selective cytotoxicity of those formulations for tumoral cells.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124889\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_36       positive      2.6836          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_36  used_to_treat      1.8503          2       0.689484\n",
        "0  drug_disease_36      may_cause      0.8333          1       0.310516\n",
        "\n",
        "In addition, when the [[glioma]] cells were exposed to 25 microM of indomethacin-loaded nanocapsules or [[indomethacin ethyl ester-loaded nanocapsules]], a necrotic cell death was observed.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124892\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "       pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_7       positive      2.6836          3              1      1\n",
        "\n",
        "       pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_7  used_to_treat      1.8503          2       0.689484\n",
        "0  drug_disease_7      may_cause      0.8333          1       0.310516"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "We describe the case of a 10-year-old boy who developed systemic weakness following treatment of [[spasticity]] with [[botulinum toxin type B]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124858\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_159       positive      2.6092          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_159      may_cause      1.8015          2       0.690442\n",
        "1  drug_disease_159  used_to_treat      0.8077          1       0.309558\n",
        "\n",
        "Compared with the general population, [[methotrexate]]-treated RA patients have an increased incidence of melanoma, non-Hodgkin's lymphoma, and [[lung cancer]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124874\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_25       positive      2.6092          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_25  used_to_treat      1.8015          2       0.690442\n",
        "0  drug_disease_25      may_cause      0.8077          1       0.309558\n",
        "\n",
        "Intra-articular injection of lidocaine before closed reduction of anterior shoulder dislocation produces the same [[pain]] relief as [[intravenous meperidine]] and diazepam.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124915\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_81       positive      2.6092          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_81      may_cause      1.8015          2       0.690442\n",
        "1  drug_disease_81  used_to_treat      0.8077          1       0.309558\n",
        "\n",
        "An inverse trend was observed between dose and multiplicity of [[colonic dysplasias]] in all drug-treated groups (P = 0.03), with animals receiving 75 mg/kg [[5-ASA]] exhibiting 56% of the number of dysplasias of the AOM/DSS controls (mean +/- SEM: 7.6 +/- 1.4 and 13.6 +/- 2.7, respectively).\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124830\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_110       positive      2.3788          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_110  used_to_treat      1.6515          2       0.694258\n",
        "0  drug_disease_110          other      0.7273          1       0.305742\n",
        "\n",
        "[[Posaconazole]], in doses of 200 mg 3 times daily, reduced breakthrough invasive fungal infections (OR 0.30; 95% CI 0.12 to 0.71) and [[aspergillosis]] incidence (OR 0.31; 95% CI 0.13 to 0.75) in patients receiving hematopoietic stem-cell transplants compared with those receiving fluconazole.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124798\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_27       positive      2.3788          3              1      1"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_27  used_to_treat      1.6515          2       0.694258\n",
        "0  drug_disease_27          other      0.7273          1       0.305742\n",
        "\n",
        "Intra-articular injection of lidocaine before closed reduction of [[anterior shoulder dislocation]] produces the same pain relief as intravenous meperidine and [[diazepam]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124822\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_82       positive      2.3788          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_82      may_cause      1.6515          2       0.694258\n",
        "1  drug_disease_82          other      0.7273          1       0.305742\n",
        "\n",
        "[[Spinal cord infarction]] secondary to [[cocaine]] use.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124879\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_231       positive      2.4833          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_231  used_to_treat      1.7333          2       0.697983\n",
        "0  drug_disease_231      may_cause      0.7500          1       0.302017\n",
        "\n",
        "We concluded that conversion to SRL in pancreas transplantation should be considered an important alternative strategy, particularly for CNI nephrotoxicity and neurotoxicity, and in cases of [[severe diarrhea]] due to [[MMF]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124716\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_192       positive      2.4221          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_192      may_cause      1.6948          2       0.699723\n",
        "1  drug_disease_192  used_to_treat      0.7273          1       0.300277\n",
        "\n",
        "The most frequent and the most troublesome adverse effect of interferon plus [[ribavirin]]-based therapy is [[anaemia]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124895\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_240       positive       2.609          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_240  used_to_treat      1.8398          2       0.705174\n",
        "0  drug_disease_240      may_cause      0.7692          1       0.294826\n",
        "\n",
        "Oral BDP prevents [[relapses of gastrointestinal GVHD]] following tapering of [[prednisone]]; survival is statistically significantly better among patients receiving BDP.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124815"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_216       positive      2.5078          3              1   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_216      may_cause      1.7745          2       0.707592\n",
        "1  drug_disease_216  used_to_treat      0.7333          1       0.292408\n",
        "\n",
        "The primary reasons for withdrawal were similar across groups except for [[gout flares]], which were more frequent with [[febuxostat]] than with allopurinol.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124706\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_33       positive      3.9401          5       0.536703      1\n",
        "1  drug_disease_33    speculative      3.4012          4       0.463297      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_33  used_to_treat      3.1068          4       0.788508\n",
        "0  drug_disease_33      may_cause      0.8333          1       0.211492\n",
        "\n",
        "Selective cytotoxicity of [[indomethacin]] and indomethacin ethyl ester-loaded nanocapsules against [[glioma]] cell lines: an in vitro study.\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124782\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "2  drug_disease_64       positive      4.1098          5       0.556567      1\n",
        "0  drug_disease_64          false      2.4619          3       0.333401      0\n",
        "1  drug_disease_64       negative      0.8125          1       0.110032      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_64          other      3.2636          4       0.794102\n",
        "1  drug_disease_64  used_to_treat      0.8462          1       0.205898\n",
        "\n",
        "There is evidence in the literature that inhaled corticosteroids ([[ICSs]]) are safe for pregnant women with [[asthma]] and their infants.\n",
        "\n",
        "============================================================\n"
       ]
      }
     ],
     "prompt_number": 31
    },
    {
     "cell_type": "markdown",
     "metadata": {},
     "source": [
      "Which work units had other as the top deep semantic choice?"
     ]
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "temp = []\n",
      "for rel_id, group in deep_sem_res.groupby(\"pub_rel_id\"):\n",
      "    if group.iloc[0][\"deep_semantics\"] == \"other\":\n",
      "        temp.append((rel_id, group.iloc[0][\"percent_agree\"]))\n",
      "        \n",
      "temp = sorted(temp, key = lambda x: x[1])\n",
      "\n",
      "\n",
      "summary(map(lambda x: x[0], temp))"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "Unit id: 706124856\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 2/3\n",
        "\n",
        "         pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  \\\n",
        "0  drug_disease_213       positive      1.6648          2       0.689415   \n",
        "1  drug_disease_213    speculative      0.7500          1       0.310585   \n",
        "\n",
        "   match  \n",
        "0      1  \n",
        "1      0  \n",
        "\n",
        "         pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_213          other      0.8571          1       0.514837\n",
        "1  drug_disease_213  used_to_treat      0.8077          1       0.485163\n",
        "\n",
        "At all doses studied, [[febuxostat]] more effectively lowered and maintained serum urate levels <6.0 mg/dl than did allopurinol (300 or 100 mg) or placebo in subjects with hyperuricemia and gout, including those with mild to moderately [[impaired renal function]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124861\n",
        "\n",
        "EU-ADR answer: speculative\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "0  drug_disease_90    speculative      2.3596          3              1      1\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "1  drug_disease_90          other      1.5904          2       0.674013\n",
        "0  drug_disease_90      may_cause      0.7692          1       0.325987\n",
        "\n",
        "Furthermore, there may be a relationship between [[statin]] dose and [[cancer]].\n",
        "\n",
        "============================================================\n",
        "Unit id: 706124782\n",
        "\n",
        "EU-ADR answer: positive\n",
        "Experts agree: 3/3\n",
        "\n",
        "        pub_rel_id broad_rel_type  conf_score  num_votes  percent_agree  match\n",
        "2  drug_disease_64       positive      4.1098          5       0.556567      1\n",
        "0  drug_disease_64          false      2.4619          3       0.333401      0\n",
        "1  drug_disease_64       negative      0.8125          1       0.110032      0\n",
        "\n",
        "        pub_rel_id deep_semantics  conf_score  num_votes  percent_agree\n",
        "0  drug_disease_64          other      3.2636          4       0.794102\n",
        "1  drug_disease_64  used_to_treat      0.8462          1       0.205898\n",
        "\n",
        "There is evidence in the literature that inhaled corticosteroids ([[ICSs]]) are safe for pregnant women with [[asthma]] and their infants.\n",
        "\n",
        "============================================================\n"
       ]
      }
     ],
     "prompt_number": 32
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": []
    }
   ],
   "metadata": {}
  }
 ]
}